GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Exactech Inc (NAS:EXAC) » Definitions » 10-Year RORE %

Exactech (Exactech) 10-Year RORE % : 0.00% (As of Sep. 2017)


View and export this data going back to 1996. Start your Free Trial

What is Exactech 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Exactech's 10-Year RORE % for the quarter that ended in Sep. 2017 was 0.00%.

The industry rank for Exactech's 10-Year RORE % or its related term are showing as below:

EXAC's 10-Year RORE % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.225
* Ranked among companies with meaningful 10-Year RORE % only.

Exactech 10-Year RORE % Historical Data

The historical data trend for Exactech's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exactech 10-Year RORE % Chart

Exactech Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Exactech Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Exactech's 10-Year RORE %

For the Medical Devices subindustry, Exactech's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exactech's 10-Year RORE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Exactech's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Exactech's 10-Year RORE % falls into.



Exactech 10-Year RORE % Calculation

Exactech's 10-Year RORE % for the quarter that ended in Sep. 2017 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( 0.01-0.86 )/( 8.35-0 )
=-0.85/8.35
=-10.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2017 and 10-year before.


Exactech  (NAS:EXAC) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Exactech 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of Exactech's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Exactech (Exactech) Business Description

Traded in Other Exchanges
N/A
Address
Exactech Inc develops, manufactures, markets, distributes and sells orthopaedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally.
Executives
Krusen W Andrew Jr director C/O FLORIDA BANKS INC, 5210 BELFORD ROAD - SUITE 310, JACKSONVILLE FL 32256
James G Binch director C/O MEMRY CORPORATION, 3 BERKSHIRE BOULEVARD, BETHEL CT 06801

Exactech (Exactech) Headlines

From GuruFocus

Exactech Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 05-05-2010

Exactech Inc. Reports Operating Results (10-K)

By gurufocus 10qk 03-16-2011

Exactech Inc. (EXAC) CEO and Chairman, 10% Owner R William Petty sells 20,000 Shares

By GuruFocus Research GuruFocus Editor 12-12-2009

Exactech Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-09-2010

Meridian Funds Comments on Exact Sciences Corp

By Holly LaFon Holly LaFon 03-08-2016

Exactech Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-05-2009

Exactech Inc. (EXAC) CFO and Treasurer Joel C Phillips sells 2,497 Shares

By GuruFocus Research GuruFocus Editor 05-04-2010

Mario Gabelli Ups His Holdings in EXAC, TWIN and LAYN

By Monica Wolfe Monica Wolfe 06-28-2013